Project Grant R35GM161467
- Federal Project Grant Award Summary The University of Minnesota received a $318,956 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award supports fundamental research aimed at making genetics research generalizable to diverse populations by developing statistical tools and methodologies to address the underrepresentation of non-European...
- Federal Project Grant Award Summary The University of Minnesota's Regents, Office of Sponsored Projects Administration, received a $492,931 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. This five-year research initiative focuses on developing multiplexed assays of variant effect (MAVE) methodologies to advance synthetic protein...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $188,627 to the Regents of the University of Minnesota under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through August 31, 2030. This Project Grant funds the development of tools and technologies for measuring post-translational modification enzyme activity, specifically focusing on kinase activity measurement both in vitro and in live cells. The...
- Federal Grant Award Summary The University of Minnesota received a $2.04 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on July 28, 2025, with a completion date of June 30, 2030. This award supports the University of Minnesota Medical Scientist Training Program (MD/PhD), which trains and develops physician scientists capable of integrating scientific research, clinical...
- Federal Grant Award Summary The University of Minnesota received a $249,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2028. The award supports fundamental research focused on developing novel methods for radical hydroamination via boryl radical chemistry. The research deliverables encompass two primary objectives: (1) the discovery and...
- Federal Project Grant Award Summary The University of Minnesota's Regents, through the Office of Sponsored Projects Administration, received a $600,000 project grant awarded February 1, 2026, under the Computer and Information Science and Engineering (CISE) program (CFDA 47.070), Division of Information and Intelligent Systems. This research initiative, scheduled for completion by January 31, 2029, develops a privacy-preserving artificial intelligence framework for identifying rare genetic...
- Federal Grant Award Summary The Regents of the University of Minnesota received a $220,000 Project Grant award from the National Science Foundation's Division of Information and Intelligent Systems (Computer and Information Science and Engineering program, CFDA 47.070) effective August 1, 2025, through July 31, 2027. This collaborative research initiative will develop generative artificial intelligence (AI) methodologies and computational tools designed to accelerate drug discovery and...
- Federal Grant Award Summary New York University received a $333,076 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with a completion date of July 31, 2029. The grant funds the development of novel statistical methods, algorithms, and computational pipelines designed to identify and characterize disease subgroups within high-dimensional omics data, including genomic,...
- Federal Project Grant Award Summary The University of Minnesota's Office of Sponsored Projects Administration received a $404,058 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. This award supports fundamental research investigating single-molecule imaging and the mechanisms of crossover regulation on meiotic chromosomes. The...
- Federal Project Grant Award Summary The University of Minnesota's Office of Sponsored Projects Administration received a Project Grant award of $373,737 from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. This R35 Maximizing Investigators' Research Award (MIRA) supports fundamental research investigating the dynamics of motile flagella in fluid media. The research...
The University of Minnesota's Regents, through its Office of Sponsored Projects Administration, received a $333,290 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) effective March 1, 2026, through February 28, 2031. This award supports the development of a comprehensive analytical framework for integrating high-throughput biomedical data across multiple sources, dimensions, and patient cohorts. The research team will create novel statistical methodology and computational tools to simultaneously identify covariate-driven effects and underlying structured variation in complex multi-dimensional datasets, with applications to neurodegenerative disorders, pulmonary disorders, early-life nutrition, and related biomedical domains. The deliverables under this grant include a flexible bidimensional regression and factorization framework capable of decomposing covariate effects and low-rank structures, development of Bayesian inference algorithms for efficient posterior sampling, missing data imputation techniques, sample cohort classification methods, and longitudinal progression tracking tools. These methodological advances will be complemented by applied research demonstrating the framework's utility across diverse biomedical areas. The award builds on the principal investigator's established track record of developing impactful statistical methods and widely-adopted software for data integration in high-throughput biomedical research settings.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $333.3k | 2/27/26 |